MedTrace Logo

Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture

NCT05106517 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2023-02-21

No results posted yet for this study

Summary

Bone mineral density and function at 1 year after screw fixation with denosumab vs zoledronic acid for osteoporotic vertebral compression fractures: a parallel double-blind randomized controlled clinical trial

Conditions

  • Denosumab vs Zoledronate

Interventions

DRUG

Denosumab

Denosumab 60mg/6 months subcutaneously + placebo iv

DRUG

Zoledronic acid

Iv zoledronic acid and placebo /6 months subcutaneously

Sponsors & Collaborators

  • Shenzhen People's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-08
Primary Completion
2023-03-05
Completion
2023-03-11

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106517 on ClinicalTrials.gov